16D0 Fortina, Paolo M. - Thomas Jefferson University - Thomas Jefferson University

Paolo M. Fortina, MD, PhD

Contact Dr. Fortina

Kimmel Cancer Center
233 S. Tenth Street, Suite 1009
Philadelphia, PA 19107

(215) 955-0683
(215) 503-9142 fax

Most Recent Peer-reviewed Publications

  1. Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- And tissue-specific microRNAs
  2. The future of laboratory medicine - A 2014 perspective
  3. Performance of exome sequencing for pharmacogenomics
  4. Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis
  5. RB loss contributes to aggressive tumor phenotypes in MYC-driven triple negative breast cancer
  6. Clinical exome performance for reporting secondary genetic findings
  7. The retinoblastoma tumor suppressor modulates DNA repair and radioresponsiveness
  8. The retinoblastoma tumor suppressor pathway modulates the invasiveness of ErbB2-positive breast cancer
  9. Human platelet m 1235 icroRNA-mRNA networks associated with age and gender revealed by integrated plateletomics
  10. The human platelet: Strong transcriptome correlations among individuals associate weakly with the platelet proteome
  11. Genomic test validation for incidental findings
  12. Clinical genomics: When whole genome sequencing is like a whole-body CT scan
  13. Bridging genomics research between developed and developing countries: The Genomic Medicine Alliance
  14. Genomics into Healthcare: The 5th Pan Arab Human Genetics Conference and 2013 Golden Helix Symposium
  15. Donor splice-site mutation in CUL4B is likely cause of X-linked intellectual disability
  16. Mechanisms of endothelial cell attachment, proliferation, and differentiation on 4 types of platinum-based endovascular coils
  17. Functional significance of macrophage-derived exosomes in inflammation and pain
  18. Developmental dysplasia of the hip: Linkage mapping and whole exome sequencing identify a shared variant in CX3CR1 in all affected members of a large multigeneration family
  19. In vivo MAPK reporting reveals the heterogeneity in tumoral selection of resistance to RAF inhibitors
  20. Cyclin D1 induction of dicer governs microRNA processing and expression in breast cancer